Qualigen Therapeutics, Inc. — Director's Dealing 2016

Jul 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2016-07-05

Reporting Person: Ritter Ira E. (Director, Exec. Chairman, CSO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-05	Non-qualified Stock Option (Right to Buy)	$1.54	A	82000	Acquired	2026-07-05	Common Stock (82000)	Direct

Footnotes

F1: The option vests in forty-eight (48) equal monthly installments, the first of which installments shall vest on July 20, 2016 with the balance vesting on the 20th day of each calendar month thereafter until vested in full.